psoriasis

sponsored content

A Deep-dive Into Specialty Pharma

A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.

presented by

Purdue and Exicure sign deal worth up to $790M

Purdue Pharma has announced a strategic partnership with Exicure, which could be worth up to $790 million and royalties if the latter's drug candidates succeed. The first disease target, psoriasis, is well outside of Purdue's painkiller market -- probably not by accident.

Skylit’s handheld device could bring psoriasis, eczema phototherapy home

San Diego startup Skylit Medical is developing a phototherapy device for private home use to treat conditions like psoriasis, eczema and vitiligo. It’s one of those necessity’s the mother of inventionish stories – founder Martyn Gross himself has eczema and psoriasis. “We are a frustrated group, because this is an inflammatory condition for which there is no cure […]

Pharma

Biotech accelerator BioMotiv, NYU unveil a new spinoff for inflammatory disease treatments

A biotech accelerator launched as part of a $250 million drug discovery initiative spearheaded by Cleveland’s University Hospitals has spun off its first company to develop promising technology for treating inflammatory diseases. Orca Pharmaceuticals is the first company announced by BioMotiv, the for-profit accelerator associated with the Harrington Discovery Project at UH. BioMotiv in- licenses […]